Literature DB >> 16762424

Sex-dependent effects of chronic restraint stress during early Theiler's virus infection on the subsequent demyelinating disease in CBA mice.

Amy N Sieve1, Andrew J Steelman, Colin R Young, Ralph Storts, Thomas H Welsh, C Jane R Welsh, Mary W Meagher.   

Abstract

Chronic restraint stress, administered during early infection with Theiler's virus, was found to exacerbate the acute CNS viral infection in male and female mice. During the subsequent demyelinating phase of disease (a model of multiple sclerosis), the effect of stress on disease progression was sex-dependent. Previously stressed male mice had less severe behavioral signs of the chronic phase, better rotarod performance and decreased inflammatory lesions of the spinal cord, while the opposite pattern was observed in females. In addition, mice in all groups developed autoantibodies to MBP, PLP139-151 and MOG33-55.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16762424     DOI: 10.1016/j.jneuroim.2006.04.020

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Interleukin-6 as a mechanism for the adverse effects of social stress on acute Theiler's virus infection.

Authors:  Mary W Meagher; Robin R Johnson; Erin E Young; Elisabeth G Vichaya; Shannon Lunt; Elizabeth A Hardin; Marilyn A Connor; C Jane R Welsh
Journal:  Brain Behav Immun       Date:  2007-06-25       Impact factor: 7.217

2.  Glucocorticoid exposure alters the pathogenesis of Theiler's murine encephalomyelitis virus during acute infection.

Authors:  Erin E Young; Thomas W Prentice; Danielle Satterlee; Heath McCullough; Amy N Sieve; Robin R Johnson; Thomas H Welsh; C Jane R Welsh; Mary W Meagher
Journal:  Physiol Behav       Date:  2008-05-07

3.  Chronic social stress impairs virus specific adaptive immunity during acute Theiler's virus infection.

Authors:  Erin E Young; Elisabeth G Vichaya; Nicole M Reusser; Jennifer L Cook; Andrew J Steelman; C Jane R Welsh; Mary W Meagher
Journal:  J Neuroimmunol       Date:  2012-09-27       Impact factor: 3.478

4.  Neonatal maternal separation alters immune, endocrine, and behavioral responses to acute Theiler's virus infection in adult mice.

Authors:  M W Meagher; A N Sieve; R R Johnson; D Satterlee; M Belyavskyi; W Mi; T W Prentice; T H Welsh; C J R Welsh
Journal:  Behav Genet       Date:  2010-02-05       Impact factor: 2.805

5.  Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice: II. CNS disease severity.

Authors:  Erin E Young; Amy N Sieve; Elisabeth G Vichaya; Luis M Carcoba; Colin R Young; Andrew Ambrus; Ralph Storts; C Jane R Welsh; Mary W Meagher
Journal:  J Neuroimmunol       Date:  2010-02-18       Impact factor: 3.478

6.  Stress-induced differences in primary and secondary resistance against bacterial sepsis corresponds with diverse corticotropin releasing hormone receptor expression by pulmonary CD11c+ MHC II+ and CD11c- MHC II+ APCs.

Authors:  Xavier F Gonzales; Aniket Deshmukh; Mark Pulse; Khaisha Johnson; Harlan P Jones
Journal:  Brain Behav Immun       Date:  2007-12-31       Impact factor: 7.217

7.  Social disruption alters pain and cognition in an animal model of multiple sclerosis.

Authors:  H R Linsenbardt; J L Cook; E E Young; E G Vichaya; C R Young; N M Reusser; R Storts; C J Welsh; M W Meagher
Journal:  J Neuroimmunol       Date:  2015-09-12       Impact factor: 3.478

8.  Host genetic background influences diverse neurological responses to viral infection in mice.

Authors:  Candice L Brinkmeyer-Langford; Raquel Rech; Katia Amstalden; Kelli J Kochan; Andrew E Hillhouse; Colin Young; C Jane Welsh; David W Threadgill
Journal:  Sci Rep       Date:  2017-09-22       Impact factor: 4.379

9.  High-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis.

Authors:  Francesca Gilli; Xi Chen; Andrew R Pachner; Barjor Gimi
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.